These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6450678)

  • 21. Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus.
    Skrha J; Perusicová J; Stolba P; Stibor V; Páv J
    Clin Chim Acta; 1987 Jul; 166(2-3):135-41. PubMed ID: 3621594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma N-acetyl-beta, D-glucosaminidase activities and glycaemia in diabetes mellitus.
    Poon PY; Davis TM; Dornan TL; Turner RC
    Diabetologia; 1983 Jun; 24(6):433-6. PubMed ID: 6350079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney and serum beta-N-acetylglucosaminidase activities in streptozotocin diabetic rats and their responses to insulin and glucagon.
    Fushimi H; Tarui S
    J Biochem; 1974 Jul; 76(1):225-7. PubMed ID: 4279908
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus.
    Agardh CD; Agardh E; Isaksson A; Hultberg B
    Clin Chem; 1991 Oct; 37(10 Pt 1):1696-9. PubMed ID: 1914168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-glycosidases and diabetic microangiopathy. I. Decreases of beta-glycosidase activities in diabetic rat kidney.
    Fushimi H; Tarui S
    J Biochem; 1976 Feb; 79(2):265-70. PubMed ID: 131796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifications of liver lysosomes in diabetic rats.
    Tessitore L; Baccino FM
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1136-40. PubMed ID: 162266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and urine glycosidase activities in diabetes mellitus.
    Price CP; Foster KJ
    Clin Biochem; 1979 Dec; 12(6):231-3. PubMed ID: 119588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary and serum N-acetyl-beta-D-glucosaminidase (NAG) activities in clinical significance].
    Kitahashi S; Saeki S; Shimojo N; Naka K; Okuda K; Kohno M
    Rinsho Byori; 1986 Jun; 34(6):687-93. PubMed ID: 3747209
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urinary NAG activity and diabetic microangiopathy].
    Clemenzia G; Laterza G; Cottone G; Scibinetti F; Russo G; Persichetti S; Sagliaschi G; Re M; Gallo G; Gallo E
    Minerva Med; 1987 Oct; 78(19):1453-5. PubMed ID: 3670689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Valibose, an alpha-glucosidase inhibitor, ameliorates the metabolic disorder of glucose and lipids and the nephropathy in streptozotocin-induced diabetic rats].
    Liu Q; Liu SN; Sun SJ; Shen ZF
    Yao Xue Xue Bao; 2013 Aug; 48(8):1227-32. PubMed ID: 24187828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum beta-N-acetylglucosaminidase isoenzymes in insulin-dependent diabetes mellitus.
    Pitkänen E; Järvisalo J; Harjanne A; Koivula T
    Enzyme; 1982; 28(1):14-7. PubMed ID: 6749490
    [No Abstract]   [Full Text] [Related]  

  • 32. N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes.
    Miralles JM; Corrales JJ; Garcia-Diez LC; Cabezas JA; Reglero A
    Clin Chim Acta; 1982 Jun; 121(3):373-8. PubMed ID: 7105401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary N-acetyl-beta-D-glucosaminidase in streptozotocin-induced diabetic rats.
    Ellis EN; Brouhard BH; LaGrone L
    Biochem Med; 1984 Jun; 31(3):303-10. PubMed ID: 6477535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients.
    Reglero A; Carretero MI; Cabezas JA
    Clin Chim Acta; 1980 Apr; 103(2):155-8. PubMed ID: 6245816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control.
    Waters PJ; Flynn MD; Corrall RJ; Pennock CA
    Diabetologia; 1992 Oct; 35(10):991-5. PubMed ID: 1451959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Stibor V; Sperl M; Stolba P; Hilgertová J
    Clin Chim Acta; 1994 Sep; 229(1-2):5-14. PubMed ID: 7988055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.
    Tominaga M; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Honda M; Mokuda O; Ikeda T; Mashiba H
    Horm Metab Res; 1989 Aug; 21(8):438-40. PubMed ID: 2793065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) during follow-up period and related factors in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1989 Jan; 37(1):37-42. PubMed ID: 2724580
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients.
    Perdichizzi G; Cucinotta D; Saitta A; Cavalieri A; Squadrito G
    Acta Diabetol Lat; 1983; 20(3):257-64. PubMed ID: 6637327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.